Results 231 to 240 of about 195,645 (350)

Correspondence to: Clinico‐sero‐pathological characteristics of anti‐Ha antisynthetase syndrome

Brain Pathology, EarlyView.
Marie‐Therese Holzer, Robert Biesen, Sarah Tansley, Carsten Dittmayer, Werner Stenzel, Udo Schneider   +5 more
wiley   +1 more source

Objective Effects and Patient Preferences for Ambulatory Oxygen in Fibrotic Interstitial Lung Disease With Isolated Exertional Hypoxaemia: A Placebo‐Controlled 6‐Minute Walk Test Study

Respirology, EarlyView.
ABSTRACT Background and Objective The available evidence on the effects of ambulatory oxygen on exercise impairment in patients with fibrotic interstitial lung diseases (F‐ILD) is of limited quality. Methods We conducted a randomised, double‐blind, placebo‐controlled crossover trial with 32 normoxaemic F‐ILD patients, desaturating to ≤ 88% during a ...
Giuseppina Ciarleglio, Paolo Cameli, David Bennett, Behar Cekorja, Paola Rottoli, Elisabetta A. Renzoni, Piersante Sestini, Elena Bargagli   +7 more
wiley   +1 more source

Delving Deeper into Genotypic-Phenotypic Associations in Idiopathic Pulmonary Fibrosis. [PDF]

Ann Am Thorac Soc
Montesi SB, Adegunsoye A.
europepmc   +1 more source

Serum anti-p53 autoantibodies from patients with idiopathic pulmonary fibrosis associated with lung cancer

, 2000
Katsuhisa Oshikawa, Y Sugiyama
openalex   +1 more source

Enhancing Interstitial Lung Disease Diagnoses Through Multimodal AI Integration of Histopathological and CT Image Data

Respirology, EarlyView.
ABSTRACT Background and Objective The diagnosis of interstitial lung diseases (ILDs) often relies on the integration of various clinical, radiological, and histopathological data. Achieving high diagnostic accuracy in ILDs, particularly for distinguishing usual interstitial pneumonia (UIP), is challenging and requires a multidisciplinary approach ...
Kris Lami, Mutsumi Ozasa, Xiangqian Che, Wataru Uegami, Yoshihiro Kato, Yoshiaki Zaizen, Naoko Tsuyama, Ichiro Mori, Shin Ichihara, Han‐Seung Yoon, Ryoko Egashira, Kensuke Kataoka, Takeshi Johkoh, Yasuhiro Kondo, Richard Attanoos, Alberto Cavazza, Alberto M. Marchevsky, Frank Schneider, Jaroslaw Wojciech Augustyniak, Amna Almutrafi, Alexandre Todorovic Fabro, Luka Brcic, Anja C. Roden, Maxwell Smith, Andre Moreira, Junya Fukuoka   +25 more
wiley   +1 more source

A Twist in the Fibrotic Tale: The Overlooked Vasculopathy in Idiopathic Pulmonary Fibrosis. [PDF]

Am J Respir Crit Care Med
Tonelli AR, Sahay S.
europepmc   +1 more source

A Patient with Exacerbation of Idiopathic Pulmonary Fibrosis Which was Resolved Probably due to the Coexisting Hyperbilirubinemia?

, 2001
Takashi Ohrui, Makoto Higuchi, Akio Kanda, Toshifumi Matsui, Emi Sato, Hidetada Sasaki   +5 more
openalex   +2 more sources

Living with idiopathic pulmonary fibrosis [PDF]

The Lancet Respiratory Medicine, 2021
openaire   +3 more sources

Add‐On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin‐Treated Mice and Patients With Pulmonary Fibrosis

Respirology, EarlyView.
ABSTRACT Background and Objective Idiopathic pulmonary fibrosis is a progressive interstitial lung disease characterised by excessive activation of myofibroblasts. However, currently available antifibrotic drugs exhibit limited efficacy. The dysregulation of redox processes plays a significant role in the pathogenesis of idiopathic pulmonary fibrosis ...
Jie Huang, Nana Liu, Yueyue Jin, Shuangyu Han, Lian Li, Yunze Du, Luqing Wei, Dongsheng Li, Yan Zhang, Yubao Wang, Jau‐Shyong Hong, Wen Ning, Jing Feng   +12 more
wiley   +1 more source

Malnutrition, Sarcopenia, and Malnutrition Sarcopenia Syndrome in Idiopathic Pulmonary Fibrosis. [PDF]

Adv Respir Med
Cabrera-César E, Fernández-Jiménez R, Lopez-Garcia J, Sanmartín-Sánchez A, Benítez Cano-Gamonoso M, Asschert Agüero I, Espíldora-Hernández F, Fernandez de Rota Garcia L, Vega-Aguilar I, Amaya-Campos MDM, Tinahones FJ, Garcia-Almeida JM, Velasco-Garrido JL.   +12 more
europepmc   +1 more source